Stereotaxis, Inc. Common Stock (STXS) Stock Price

STXSStock

$1.01−66.67%52W

Market Cap$101.20M

P/E—

PEG Ratio1.31

Div yield—

Beta1.41

STXS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-60.15%

Price vs S&P 500 (4W)-24.41%

PEG Ratio1.31

VGM Score23.60

Book Value / Share (Quarterly)$0.18

P/TBV (Annual)17.46x

Revenue Growth (3Y)4.77%

Cash Flow / Share (Quarterly)$-0.16

Price vs S&P 500 (YTD)-68.01%

Gross Margin (TTM)55.57%

Net Profit Margin (TTM)-74.24%

EPS (TTM)$-0.23

10-Day Avg Trading Volume0.63M

EPS Excl Extra (TTM)$-0.23

Revenue Growth (5Y)3.99%

EPS (Annual)$-0.24

ROI (Annual)-115.61%

Gross Margin (Annual)52.73%

Net Profit Margin (5Y Avg)-65.83%

Cash / Share (Quarterly)$0.11

Revenue Growth QoQ (YoY)-12.82%

ROA (Last FY)-41.42%

Revenue Growth TTM (YoY)-5.47%

EBITD / Share (TTM)$-0.23

ROE (5Y Avg)-100.98%

Operating Margin (TTM)-75.68%

Cash Flow / Share (Annual)$-0.14

P/B Ratio5.79x

P/B Ratio (Quarterly)9.64x

Net Income / Employee (Annual)$-165,200

EV / Revenue (TTM)3.02x

Net Interest Coverage (TTM)-1071.00x

ROA (TTM)-43.04%

EV / EBITDA (TTM)197.20x

EPS Incl Extra (Annual)$-0.24

Current Ratio (Annual)1.51x

Quick Ratio (Quarterly)0.91x

3-Month Avg Trading Volume0.75M

52-Week Price Return-66.67%

Revenue / Employee (TTM)$229,500

Tangible BV / Share (Quarterly)$0.12

P/S Ratio (Annual)3.13x

Asset Turnover (Annual)0.62x

52-Week High$3.19

Operating Margin (5Y Avg)-68.12%

EPS Excl Extra (Annual)$-0.24

CapEx CAGR (5Y)5.85%

Tangible BV CAGR (5Y)28.64%

26-Week Price Return-50.25%

Quick Ratio (Annual)1.05x

13-Week Price Return-34.84%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)1.42x

Enterprise Value$90.71M

Revenue / Share Growth (5Y)-0.55%

Asset Turnover (TTM)0.58x

Book Value / Share Growth (5Y)-18.49%

Revenue / Employee (Annual)$247,200

Inventory Turnover (Annual)1.71x

Pretax Margin (Annual)-66.85%

Cash / Share (Annual)$0.14

3-Month Return Std Dev48.27%

Gross Margin (5Y Avg)58.88%

Net Income / Employee (TTM)$-170,400

ROE (Last FY)-115.61%

Net Interest Coverage (Annual)-156.00x

EPS Basic Excl Extra (Annual)$-0.24

P/FCF (TTM)80.07x

Receivables Turnover (TTM)5.04x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.23

Receivables Turnover (Annual)6.70x

ROI (TTM)-132.62%

P/S Ratio (TTM)3.37x

Pretax Margin (5Y Avg)-65.83%

Revenue / Share (Annual)$0.36

Tangible BV / Share (Annual)$0.13

Price vs S&P 500 (52W)-82.20%

Year-to-Date Return-56.09%

5-Day Price Return-11.40%

EPS Normalized (Annual)$-0.24

ROA (5Y Avg)-38.82%

Net Profit Margin (Annual)-66.85%

Month-to-Date Return-17.89%

Cash Flow / Share (TTM)$-0.26

EBITD / Share (Annual)$-0.24

Operating Margin (Annual)-69.81%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-100.98%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.23

P/TBV (Quarterly)14.62x

P/B Ratio (Annual)11.47x

Inventory Turnover (TTM)1.21x

Pretax Margin (TTM)-74.24%

Book Value / Share (Annual)$0.20

Price vs S&P 500 (13W)-37.52%

Beta1.41x

Revenue / Share (TTM)$0.30

ROE (TTM)-132.62%

52-Week Low$1.00

vGradeD

gGradeF

mGradeD

vgmGradeD

STXS Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 11, 2026	-$0.05	-$0.05	-7.14%(-$0.00)
Q4 2025	Mar 9, 2026	-$0.07	-$0.06	+7.69%(+$0.01)
Q3 2025	Nov 11, 2025	-$0.06	-$0.07	-16.67%(-$0.01)
Q2 2025	Aug 7, 2025	-$0.07	-$0.05	+23.08%(+$0.02)

STXS Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.10

4.11

Industry Peers — Electromedical Equipment(31)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
STXSStereotaxis, Inc. Common Stock	D	F	D	3.4x	4.0%	55.6%	-75.7%	$1.01
MDTMedtronic plc	B	C	B	3.2x	3.8%	65.7%	18.1%	$94.75
ITGRInteger Holdings Corporation	C	C	A	2.3x	11.6%	26.1%	9.7%	$126.70
LIVNLivaNova PLC Ordinary Shares	C	B	B	2.9x	8.2%	68.1%	12.5%	$77.58
TMDXTransMedics Group, Inc. Common Stock	C	B	D	3.7x	88.2%	58.7%	12.2%	$70.78
AXGNAxogen, Inc. Common Stock	F	B	B	8.1x	14.9%	74.6%	-11.8%	$34.62
BLFSBioLife Solutions Inc.	F	C	A	18.4x	14.9%	63.9%	2.9%	$38.61
CNMDCONMED Corporation	B	C	B	1.0x	9.8%	55.8%	8.0%	$46.72
CBLLCeriBell, Inc. Common Stock	F	A	A	9.4x	—	88.9%	-68.6%	$25.04
INMDInMode Ltd. Ordinary Shares	A	D	C	2.2x	12.4%	76.5%	18.5%	$14.16
CVCapsoVision, Inc. Common Stock	F	D	B	25.0x	—	50.9%	-217.1%	$6.53
ELMDElectromed, Inc.	C	B	C	3.1x	15.6%	78.5%	18.8%	$27.42
FOCLEDAP TMS S.A. American Depositary Shares	C	C	D	2.3x	9.4%	47.6%	-40.7%	$4.09
VANIVivani Medical, Inc. Common Stock (DE)	—	—	C	29.9x	—	36.4%	-1004.7%	$1.12
NRXSNeuraxis, Inc.	F	A	A	18.2x	13.1%	85.5%	-144.5%	$7.70
STEXStreamex Corp. Common Stock	—	C	F	298.3x	—	100.0%	-10384.3%	$0.37
HYPRHyperfine, Inc. Class A Common Stock	C	A	D	4.8x	115.2%	51.4%	-203.3%	$0.75
OMOutset Medical, Inc. Common Stock	A	C	C	0.6x	19.1%	41.8%	-56.1%	$3.94
ECORelectroCore, Inc. Common Stock	C	A	B	1.9x	55.7%	87.5%	-37.6%	$7.85
POCIPrecision Optics Corporation, Inc. Common Stock	C	A	C	1.5x	24.2%	17.2%	-11.1%	$4.32
QTIQT Imaging Holdings, Inc. Common Stock	C	A	D	1.3x	—	40.4%	-56.2%	$2.40
ITOCiTonic Holdings Ltd Class A Ordinary Shares	—	A	C	50.5x	—	60.9%	-1776.4%	$3.84
IRIXIridex Corp	B	D	D	0.3x	7.7%	35.9%	-5.4%	$0.81
NDRAENDRA Life Sciences Inc. Common Stock	D	—	C	19.2x	—	51.4%	-1921.6%	$4.74
NXLNexalin Technology, Inc. Common Stock	D	D	F	11.3x	4.4%	86.2%	-4202.4%	$2.35
NUWENuwellis, Inc. Common Stock	—	D	F	0.2x	2.1%	69.7%	-142.9%	$0.55
EDAPEDAP TMS SA	D	C	C	2.2x	9.4%	46.6%	-37.3%	$3.99
EYESCorgi Data & Surveillance ETF	—	C	C	—	—	—	—	$28.78
FONRFonar Corporation	B	D	B	1.3x	4.0%	40.3%	9.1%	$0.00
MASIMasimo Corporation	D	D	B	6.0x	6.0%	61.7%	19.9%	$0.00
QSIAWQuantum-Si Incorporated Warrant	—	—	F	—	—	—	—	$0.00
TIVCTivic Health Systems, Inc. Common Stock	—	B	F	8.4x	13.2%	-58.1%	-1549.0%	$2.49

About Stereotaxis, Inc. Common Stock

Stereotaxis Inc specializes in robotic technologies for cardiac arrhythmia treatment and endovascular procedures, providing interventional labs with precision surgical systems and integrated procedural information solutions. The company generates revenue primarily through disposables and service, supplemented by systems sales, royalties, and facility subleases.

STXS Next Earnings Report

Report dateNov 16, 2026

QuarterQ3 2026

Report timeAMC

EPS estimate-$0.06

Revenue estimate$9.60M

Also reporting on Nov 16, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

Companies in Related Industries

NYXHNyxoah SA Ordinary SharesSurgical & Medical Instruments
SEERSeer, Inc. Class A Common StockLab Analytical Instruments
CODACoda Octopus Group, Inc. Common stockDefense Systems & Equipment
APYXApyx Medical Corporation Common StockSurgical & Medical Instruments
PYPDPolyPid Ltd. Ordinary SharesSurgical & Medical Instruments
KEQUKewaunee Scientific CorpLab Apparatus & Furniture
LUCDLucid Diagnostics Inc. Common StockSurgical & Medical Instruments
LAKELakeland Industries IncOrthopedic & Prosthetic Devices

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.1

Buy

Consensus rating

52-Week Range

Low$1.00

High$3.19